Similar articles

• Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis.

  Allen CT, Lee S, Norberg SM, Kovalovsky D, Ye H, Clavijo PE, Hu-Lieskovan S, Schlegel R, Schlom J, Strauss J, Gulley JL, Trepel J, Hinrichs CS. Allen CT, et al. J Immunother Cancer. 2019 May 3;7(1):119. doi: 10.1186/s40425-019-0603-3. J Immunother Cancer. 2019. PMID: 31053174 Free PMC article. Clinical Trial.
• Recurrent laryngeal papillomatosis with oesophageal involvement in a 2 year old boy: successful treatment with the quadrivalent human papillomatosis vaccine.

  Mészner Z, Jankovics I, Nagy A, Gerlinger I, Katona G. Mészner Z, et al. Int J Pediatr Otorhinolaryngol. 2015 Feb;79(2):262-6. doi: 10.1016/j.ijporl.2014.11.022. Epub 2014 Nov 25. Int J Pediatr Otorhinolaryngol. 2015. PMID: 25496821
• Lower airway papillomatosis in children.

  Zawadzka-Głos L, Jakubowska A, Chmielik M, Bielicka A, Brzewski M. Zawadzka-Głos L, et al. Int J Pediatr Otorhinolaryngol. 2003 Oct;67(10):1117-21. doi: 10.1016/s0165-5876(03)00191-5. Int J Pediatr Otorhinolaryngol. 2003. PMID: 14550967
• Recurrent respiratory papillomatosis.

  Venkatesan NN, Pine HS, Underbrink MP. Venkatesan NN, et al. Otolaryngol Clin North Am. 2012 Jun;45(3):671-94, viii-ix. doi: 10.1016/j.otc.2012.03.006. Otolaryngol Clin North Am. 2012. PMID: 22588043 Free PMC article. Review.
• Recurrent respiratory papillomatosis.

  Bauman NM, Smith RJ. Bauman NM, et al. Pediatr Clin North Am. 1996 Dec;43(6):1385-401. doi: 10.1016/s0031-3955(05)70524-1. Pediatr Clin North Am. 1996. PMID: 8973518 Review.